Benefit/risk balance of nanoparticle-based drugs
Nanoparticles and drugs

Add to my library

NM4012 V1 Quizzed article

Benefit/risk balance of nanoparticle-based drugs
Nanoparticles and drugs

Authors : Ariane BOUDIER, Arnaud PALLOTTA, Igor CLAROT

Review date: January 5, 2021 | Lire en français

Add to my library Add to my library

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

4. Benefit/risk balance of nanoparticle-based drugs

4.1 Concept of benefit/risk balance

As mentioned in the 2 section of this article, a drug can be formulated in a nanoparticle (encapsulation) or be the nanoparticle itself. For example, the aim is to:

  • improve or control bioavailability...

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Ongoing reading
Benefit/risk balance of nanoparticle-based drugs

Article included in this offer

"Healthcare technologies"

( 126 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details
Contact us